Specialty Overview

Best Hospitals for Hematopoietic Stem Cell Transplantation (HSCT) in India

90 hematology hospitals in our India network are listed, across 5 cities (Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai), accredited by JCI, NABH, ISO, NABL, with 51,822 beds combined.

90
Hospitals Listed
5
Cities
4.5
Avg. Rating
5
Accreditation Types
The Short Answer

This page lists the hematology hospitals in our directory offering Hematopoietic Stem Cell Transplantation (HSCT) in India, including Nanavati Super Specialty Hospital, Apollo Hospitals, Medanta - The Medicity, Artemis Hospital and others. Hospitals are listed across Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Each listing links through to the hospital's full profile page.

Ask us about hematopoietic stem cell transplantation (hsct) in India

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for Hematopoietic Stem Cell Transplantation (HSCT) in India

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviews350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Apollo Hospitals

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviews1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviews1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviews1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviews629 beds
Specialties & Accreditation
OncologyCancer Center
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Max Super Specialty Hospital

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviews500 beds
Specialties & Accreditation
CardiacLiver Transplant
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
Narayana Health

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviews1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Yashoda Hospitals, Hi-Tech City

🇮🇳 Yashoda Hospitals, Hi-Tech City

Hi-Tech City, Hyderabad, India 4.8 (742 reviews) 2,000 beds
Why consider this hospital?
4.8/5 rating from 742 reviews2,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsOrgan Transplant
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering hematopoietic stem cell transplantation (hsct) can be cared for by Yashoda Hospitals, Hi-Tech City's care team in Hi-Tech City, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Hi-Tech City, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing hematopoietic stem cell transplantation (hsct).

4.8/5
Rating
1989
Established
2,000
Beds
Hi-Tech City, Hyderabad, India
Location

Top Hematology Doctors in India

Dr. Rahul Bhargava Featured

Dr. Rahul Bhargava

MBBS, MD (General Medicine), DM (Clinical Hematology), Advanced Fellowship in Unrelated and Haploidentical Transplant
Principal Director & Chief – Hematology · Specialty: Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Hematologist & BMT Specialist
  • Principal Director – Hemato-Oncology, Fortis Memorial Research Institute, Gurugram
  • Head of Hematology and BMT, Artemis Hospital, Gurugram
Expertise & Procedures
  • Autologous Bone Marrow Transplant
  • Allogeneic Bone Marrow Transplant
  • Haploidentical BMT
  • Unrelated Donor BMT
  • Peripheral Blood Stem Cell Transplantation
View all procedures →
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Image not available

Dr. Arun Singh Danewa

MBBS, MD (Pediatrics), Pediatric Oncology Training, Fellowship in Bone Marrow Transplantation
Sr. Consultant — Pediatric Hematology, Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Pediatric Hematologist & BMT Specialist
  • Senior Consultant — Pediatric Hematology, Oncology, Bone Marrow Transplant, Artemis Hospital, Gurugram
  • Pediatric Oncology Fellowship, Sir Ganga Ram Hospital, New Delhi
Expertise & Procedures
  • Allogeneic Bone Marrow Transplant
  • Autologous Bone Marrow Transplant
  • Haploidentical Stem Cell Transplant
  • Matched Sibling Donor Transplant for Thalassemia
  • Bone Marrow Aspiration & Biopsy
View all procedures →
Pediatric Hematologist & BMT Specialist Experience: 10+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Image not available

Dr. Gaurav Dixit

MBBS, MD (General Medicine), DM (Clinical Haematology), Professional Certificate in Multiple Myeloma
Head — Haematology Oncology & Bone Marrow Transplant (Unit II) · Specialty: Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India17+ Years experience
Why consider this doctor?
  • 17+ years of experience in Hematologist & BMT Specialist
  • Head — Haematology Oncology & Bone Marrow Transplant (Unit II), Artemis Hospital, Gurugram
  • Senior Consultant — Haematology & BMT, Action Cancer Hospital, Delhi
Expertise & Procedures
  • Autologous Stem Cell Transplant
  • Matched Sibling Allogeneic Stem Cell Transplant
  • Haploidentical Stem Cell Transplant
  • Matched Unrelated Donor Transplant
  • Bone Marrow Aspiration & Biopsy
View all procedures →
Hematologist & BMT Specialist Experience: 17+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Image not available

Dr. Vikas Dua

MBBS, MD (Paediatrics), FNB (Paediatric Hematology Oncology), Fellowship in Paediatric Bone Marrow Transplant, Outreach Programme in Paediatric BMT
Principal Director & Head — Paediatric Haematology, Haemato-Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Pediatric Hematologist & BMT Specialist
  • Principal Director & Head — Paediatric Haematology, Haemato-Oncology and BMT, Fortis Memorial Research Institute, Gurgaon
  • Senior Consultant — Paediatric Hemato-Oncology and BMT, Artemis Hospital, Gurgaon
Expertise & Procedures
  • Allogeneic Bone Marrow Transplant
  • Matched Sibling Donor Transplant
  • Matched Unrelated Donor Transplant
  • Haploidentical Paediatric Stem Cell Transplant
  • Autologous Stem Cell Transplant
View all procedures →
Pediatric Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Rayaz Ahmed

Dr. Rayaz Ahmed

MBBS, MD (Pathology), DM (Clinical Hematology)
Director — Hematology & Bone Marrow Transplantation · Specialty: Hematologist & BMT Specialist
Max Super Speciality Hospital, Saket New Delhi, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Hematologist & BMT Specialist
  • Director — Hematology & Bone Marrow Transplantation, Max Super Speciality Hospital, Saket, New Delhi
  • Senior Consultant — Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
Expertise & Procedures
  • Autologous bone marrow / peripheral blood stem cell transplant
  • Allogeneic matched sibling donor stem cell transplant
  • Haplo-identical stem cell transplant
  • Matched unrelated donor stem cell transplant
  • Bone marrow aspiration and biopsy
View all procedures →
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Max Super Speciality Hospital, SaketHospital accreditation: NABH, JCI
Image not available

Dr. Ajay Gupta

MBBS, MD, DM, FRACP, Fellowship in Pediatric Bone Marrow Transplantation, Fellowship in Leukemia and Bone Marrow Transplantation
Senior Consultant — Hematology · Specialty: Hematologist & Bone Marrow Transplant Specialist
Indraprastha Apollo Hospital New Delhi, India17+ Years experience
Why consider this doctor?
  • 17+ years of experience in Hematologist & Bone Marrow Transplant Specialist
  • Senior Consultant — Hematology, Indraprastha Apollo Hospital, New Delhi — Present
  • Specialist in Bone Marrow Transplantation and Leukemia Management — Indraprastha Apollo Hospital, New Delhi
Expertise & Procedures
  • Allogeneic Bone Marrow Transplantation
  • Autologous Stem Cell Transplantation
  • Haploidentical Bone Marrow Transplantation
  • Peripheral Blood Stem Cell Mobilization and Harvesting
  • Pediatric Bone Marrow Transplantation
View all procedures →
Hematologist & Bone Marrow Transplant Specialist Experience: 17+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Our Methodology

How we selected these hospitals

A hospital appears on this page when Hematology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Hematopoietic Stem Cell Transplantation (HSCT) in India?

Choosing the right hospital for hematopoietic stem cell transplantation (hsct) is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include hematology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Hematopoietic Stem Cell Transplantation (HSCT)

Haematopoietic Stem Cell Transplantation (HSCT), commonly known as Bone Marrow Transplantation (BMT), is a life-saving procedure used to reconstitute a patient's haematopoietic system following high-dose chemotherapy or radiation, with allogeneic HSCT achieving long-term disease-free survival rates of 50–80% depending on disease type, donor compatibility, and patient fitness.

30–60 days (inpatient; varies by transplant type — autologous typically 21–35 days, allogeneic 40–60 days)
Hospital Stay
10–16 weeks from transplant day (fit-to-fly clearance requires stable engraftment, absence of active GVHD, ANC ≥ 0.5 × 10⁹/L sustained, and infectious disease clearance by the treating haematologist)
Total Stay in Country (Fit-to-Fly)
50–80% long-term disease-free survival (disease- and donor-dependent; autologous HSCT for multiple myeloma: 70–85%; matched sibling allogeneic HSCT for AML in CR1: 55–70%)
Success Rate

Clinical Overview

  • Haematopoietic Stem Cell Transplantation (HSCT) is the infusion of pluripotent haematopoietic progenitor cells — sourced from bone marrow, peripheral blood, or umbilical cord blood — into a conditioned recipient with the goal of restoring normal haematopoiesis and, in allogeneic settings, inducing a graft-versus-tumour (GVT) immune effect.
  • The procedure is broadly classified as autologous (patient's own stem cells re-infused after myeloablative chemotherapy) or allogeneic (donor cells from a matched sibling, matched unrelated donor, haploidentical relative, or cord blood unit).
  • The physiological impact is profound: conditioning regimens such as BuCy (busulfan + cyclophosphamide), FluBu (fludarabine + busulfan), or TBI-based protocols ablate the recipient's marrow, rendering them profoundly immunosuppressed and pancytopenic for 2–6 weeks before donor engraftment restores marrow function.
Full details →

Who is a Candidate?

  • ELIGIBLE CONDITIONS (Malignant): Acute Myeloid Leukaemia (AML) in CR1/CR2, Acute Lymphoblastic Leukaemia (ALL) in CR1 (high-risk) or CR2, Chronic Myeloid Leukaemia (CML) in accelerated/blast phase or TKI-refractory, Myelodysplastic Syndromes (MDS) with IPSS-R intermediate or higher, Hodgkin and Non-Hodgkin Lymphoma (relapsed/refractory or high-risk), Multiple Myeloma (autologous HSCT as consolidation post-induction), Myelofibrosis (allogeneic HSCT for DIPSS+ intermediate-2 or high risk)
  • ELIGIBLE CONDITIONS (Non-Malignant): Severe Aplastic Anaemia (SAA), Thalassaemia Major (Lucarelli Class I–III), Sickle Cell Disease with major organ complications, SCID and primary immunodeficiencies, Fanconi Anaemia, Wiskott-Aldrich Syndrome, Hurler Syndrome and selected lysosomal storage disorders, POEMS syndrome
  • ELIGIBLE CONDITIONS (Autoimmune — Investigational/Specialist Centres): Refractory Multiple Sclerosis (MS), Systemic Sclerosis, Crohn's Disease (autologous HSCT under EBMT guidelines)
  • REQUIRED PRE-TRANSPLANT DIAGNOSTICS: Bone marrow biopsy and trephine with cytogenetics (karyotype, FISH), molecular profiling (NGS panel for FLT3, NPM1, IDH1/2, TP53, ASXL1), HLA typing (high-resolution 10/10 allele-level for patient and donor), PET-CT scan (for lymphoma patients to confirm complete remission pre-transplant), ECHO (left ventricular ejection fraction must typically be ≥ 45%), Pulmonary Function Tests (DLCO ≥ 50% predicted), Creatinine clearance (GFR ≥ 40–60 mL/min depending on regimen), Liver function and bilirubin (Child-Pugh scoring), CMV/EBV/HSV/VZV/HBV/HCV/HIV serology for patient and donor, HCT-CI comorbidity scoring, Dental clearance and ENT evaluation, Fertility counselling and sperm/oocyte cryopreservation discussion
  • +1 more

Treatment Options & Approaches

  • AUTOLOGOUS HSCT (Auto-SCT):

Recovery

  • PHASE 1 — INITIAL ASSESSMENT & GAF HEALTHCARE CASE REVIEW (Weeks -12 to -8 before transplant):

Risks to be aware of

  • HSCT carries significant treatment-related morbidity and mortality that every patient and family must understand prior to proceeding.
  • The overall treatment-related mortality (TRM) at 100 days ranges from 2–5% for autologous HSCT in fit patients to 10–25% for myeloablative allogeneic HSCT in high-risk or older patients, largely driven by infection, organ toxicity, and GVHD.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive end-to-end non-medical support for international HSCT patients and their attendants, ensuring that logistical complexity never becomes a barrier to accessing life-saving treatment.

Common questions about Hematopoietic Stem Cell Transplantation (HSCT)

What is the cost of Haematopoietic Stem Cell Transplantation (HSCT) / Bone Marrow Transplantation in India versus the UAE?
The total in-hospital cost of HSCT varies significantly based on the transplant type (autologous vs. allogeneic), donor source (matched sibling, matched unrelated, or haploidentical), conditioning regimen intensity, length of inpatient stay, and any complications requiring additional intervention. In India, autologous HSCT (e.g., for multiple myeloma or lymphoma) typically costs between USD 18,000 and USD 28,000 inclusive of conditioning chemotherapy, stem cell collection and cryopreservation, the transplant admission (21–35 days), supportive medications, blood products, and standard monitoring. Allogeneic HSCT — matched sibling, MUD, or haploidentical — costs between USD 28,000 and USD 45,000, with higher costs driven by longer inpatient stays (40–60 days), GVHD prophylaxis drugs (tacrolimus, sirolimus, ATG), and intensive infection surveillance. These costs reflect care at NABH- and JCI-accredited centres in cities such as Mumbai, Delhi, Bengaluru, Chennai, and Hyderabad, which collectively perform among the highest volumes of HSCT in Asia. In the UAE (Dubai and Abu Dhabi), the same procedures are priced at USD 45,000–65,000 for autologous HSCT and USD 70,000–110,000 for allogeneic HSCT. UAE centres offer premium single-room accommodation, internationally trained nursing staff with lower nurse-to-patient ratios, and luxury patient services, along with JCI accreditation and DHA/DOH regulatory oversight. These costs are still 60–75% below equivalent procedures in the United States (where allo-HSCT routinely exceeds USD 300,000–500,000) or the United Kingdom. Neither range includes international matched unrelated donor (MUD) search and procurement fees (typically USD 5,000–20,000 depending on the registry and urgency), pre-transplant diagnostics conducted abroad, post-discharge outpatient medications, or return flights and accommodation. GAF Healthcare provides a fully itemised, personalised cost estimate within 5–7 business days of receiving complete medical records.
How long do I need to stay in India or the UAE before I am fit to fly home after HSCT?
HSCT requires one of the longest mandatory in-country stays of any medical procedure, and patients and families must plan accordingly. The minimum in-country duration before fit-to-fly clearance is 10–16 weeks from the day of stem cell infusion (Day 0), though the median for allogeneic HSCT patients is 12–14 weeks. The hospital inpatient admission itself lasts 21–35 days for autologous HSCT and 40–60 days for allogeneic HSCT (longer if complications such as GVHD, CMV reactivation, or prolonged engraftment occur). Following discharge from the inpatient unit, patients are not fit to fly and must remain near the transplant centre for outpatient monitoring. During this phase, patients are seen 3–5 times per week (reducing to weekly as recovery progresses) for blood counts, drug level monitoring, GVHD assessment, and infectious surveillance. Formal fit-to-fly clearance is issued by the transplant physician when ALL of the following criteria are met: - Absolute Neutrophil Count (ANC) sustainably above 1.0 × 10⁹/L without G-CSF support - Platelet count ≥ 50 × 10⁹/L (or ≥ 80 × 10⁹/L for long-haul flights > 8 hours, at many centres) - No active GVHD Grade II or above requiring escalation of therapy - No active systemic infection (bacterial, fungal, or viral) - Stable oral immunosuppression with documented therapeutic drug levels - ECOG Performance Status ≤ 2 (patient can perform basic self-care and ambulate) - No supplemental oxygen requirement For allogeneic HSCT patients, fit-to-fly is rarely achievable before Week 10 post-transplant, and the majority are cleared between Weeks 12 and 16. Autologous HSCT patients may occasionally achieve fit-to-fly clearance as early as Week 6–8, but Week 8–12 is more typical. These timelines can be extended by complications. GAF Healthcare's Case Manager works with the transplant team to coordinate fit-to-fly certification, arrange medical escort if required, and liaise with airlines regarding oxygen requirements, preboarding, and infection precautions during travel.
What is the success rate of HSCT / Bone Marrow Transplantation?
The success rate of HSCT is not a single number — it is disease-specific, risk-stratified, and dependent on multiple patient, disease, and transplant-related factors. Published outcomes from EBMT (European Bone Marrow Transplantation Registry), CIBMTR (Center for International Blood and Marrow Transplant Research), and individual high-volume centres provide the most reliable benchmark data. KEY OUTCOME BENCHMARKS BY DISEASE AND TRANSPLANT TYPE: - Autologous HSCT for Multiple Myeloma (MM): 5-year progression-free survival (PFS) of 40–55% with modern induction (VRd or Dara-VRd) plus autologous transplant and lenalidomide maintenance; overall survival (OS) exceeds 70–80% at 5 years with tandem auto approach in high-risk disease. - Autologous HSCT for Hodgkin Lymphoma (relapsed/refractory, chemosensitive): 5-year OS of 50–60%; when combined with brentuximab vedotin consolidation post-transplant, 5-year PFS improves to approximately 65%. - Allogeneic HSCT for AML in First Complete Remission (CR1), standard-risk: 5-year disease-free survival (DFS) of 55–70% with matched sibling donor; 50–65% with MUD; approximately 45–60% with haploidentical (PTCy protocol). - Allogeneic HSCT for ALL in CR1 (high-risk, Ph+ or MRD-positive): 5-year DFS of 50–65% with MSD; outcomes are strongly influenced by MRD negativity at transplant. - Allogeneic HSCT for Severe Aplastic Anaemia (SAA) with MSD in patients < 40 years: 5-year OS exceeding 85–90%, making it potentially curative in the majority. - Allogeneic HSCT for Thalassaemia Major (Lucarelli Class I): event-free survival (EFS) of 85–93% in paediatric patients with MSD and good pre-transplant hepatic status. - Allogeneic HSCT for MDS (IPSS-R High/Very High): 3-year OS of 35–50%, heavily dependent on cytogenetic risk and MRD status at transplant. CRITICAL PROGNOSTIC FACTORS: The Disease Risk Index (DRI) — low, intermediate, high, and very high — is the most validated risk stratification tool and correlates strongly with post-HSCT survival. Low-DRI patients achieve 3-year OS > 65%; very-high-DRI patients < 30%. The HCT-CI (Haematopoietic Cell Transplantation Comorbidity Index) predicts treatment-related mortality independent of disease. KPS/ECOG performance status, CMV serostatus, MRD negativity at transplant, and donor-recipient sex mismatch also independently influence outcomes. GAF Healthcare's partner centres in India and the UAE report outcomes that are broadly consistent with published EBMT and CIBMTR registry data, reflecting their volume, experience, and protocol adherence. During the case review process, GAF Healthcare will share the transplant centre's disease-specific outcome data and help patients and families interpret the individualised risk-benefit assessment provided by the treating haematologist.

How GAF Healthcare Assists in Choosing the Best Hospital for Hematopoietic Stem Cell Transplantation (HSCT) in India

Discover the Top Hospitals for Hematopoietic Stem Cell Transplantation (HSCT) in India

This page lists 90 accredited hematology hospitals in India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about hematopoietic stem cell transplantation (hsct) in India

How many hematology hospitals are listed in India?
90 hospitals in our India directory are currently listed for hematology including Hematopoietic Stem Cell Transplantation (HSCT).
How do you choose which hospitals to list?
A hospital appears on this page when Hematology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Which cities in India have hematology hospitals listed?
Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Use the city links on this page to view hospitals in a specific city.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, ISO, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for hematopoietic stem cell transplantation (hsct)?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about hematopoietic stem cell transplantation (hsct) in India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for hematopoietic stem cell transplantation (hsct) in India.

Contact us to report an inaccuracy on this page.